Summary Summary Short summary of a recent publication, written by scientific experts.
People positive for the anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5+) are a distinct group from people with myositis, and have a systemic syndrome composed of 3 different entities with different prognoses.
The finding underlies the importance of anti-MDA5 antibody screening in people with seronegative polyarthritis and people with interstitial pneumonia, with a suspicion of autoimmune features.
International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.
No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.